home / stock / mdxg / mdxg news


MDXG News and Press, MiMedx Group Inc From 05/03/22

Stock Information

Company Name: MiMedx Group Inc
Stock Symbol: MDXG
Market: OTC
Website: mimedx.com

Menu

MDXG MDXG Quote MDXG Short MDXG News MDXG Articles MDXG Message Board
Get MDXG Alerts

News, Short Squeeze, Breakout and More Instantly...

MDXG - MiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79M

MiMedx Group press release (NASDAQ:MDXG): Q1 GAAP EPS of -$0.11 misses by $0.01. Revenue of $58.89M (-1.4% Y/Y) beats by $4.79M. For further details see: MiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79M

MDXG - MIMEDX Announces First Quarter 2022 Operating and Financial Results

First Quarter Net Sales of $58.9 Million Reflects Double-Digit Revenue Increase for the Third Straight Quarter in the Company's Continuing Portfolio of Products Management to Host Conference Call on May 4, 2022, at 8:30 AM ET MARIETTA, Ga., May 03, 2022 (GLOBE NEWSWIRE) --...

MDXG - MIMEDX Comments on Prescience Point's Recent Filing

Shareholders Urged to Support MIMEDX Board MARIETTA, Ga., April 29, 2022 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today issued the following statement in response ...

MDXG - MIMEDX to Host First Quarter 2022 Operating and Financial Results Conference Call on May 4

MARIETTA, Ga., April 20, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that it will report operating and financial results for the first quarter ended March ...

MDXG - MIMEDX to Present Health Economics Clinical Data for EPIFIX® in Treatment of Lower Extremity Diabetic Ulcers at SAWC Spring

Company to Sponsor Symposium and Present Three Poster Abstracts MARIETTA, Ga., April 05, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced it will spon...

MDXG - MiMedx Group (MDXG) Presents at the Canaccord Genuity Musculoskeletal Conference - Slideshow

The following slide deck was published by MiMedx Group, Inc. in conjunction with this event. For further details see: MiMedx Group (MDXG) Presents at the Canaccord Genuity Musculoskeletal Conference - Slideshow

MDXG - WoundGenex Partners with MIMEDX to Launch Premier Graft Program to Wound Care Providers Nationwide

WoundGenex Partners with MIMEDX to Launch Premier Graft Program to Wound Care Providers Nationwide PR Newswire TAMPA, Fla. , March 16, 2022 /PRNewswire/ -- Leading wound care management and clinical services provider, WoundGenex, today announced a st...

MDXG - MIMEDX to Present at the Canaccord Genuity Musculoskeletal Conference

MARIETTA, Ga., March 15, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Peter M. Carlson, Chief Financial...

MDXG - MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q4 2021 Results - Earnings Call Transcript

MiMedx Group, Inc. (MDXG) Q4 2021 Earnings Conference Call February 28, 2022 17:00 ET Company Participants Jack Howarth - Senior Vice President, Investor Relations Tim Wright - Chief Executive Officer Pete Carlson - Chief Financial Officer Rohit Kashyap - Executive Vice President and Chief Co...

MDXG - MiMedx Group GAAP EPS of $0.01 beats by $0.04, revenue of $67.29M beats by $3.6M

MiMedx Group press release (NASDAQ:MDXG): Q4 GAAP EPS of $0.01 beats by $0.04. Revenue of $67.29M (-1.1% Y/Y) beats by $3.6M. For further details see: MiMedx Group GAAP EPS of $0.01 beats by $0.04, revenue of $67.29M beats by $3.6M

Previous 10 Next 10